Reagent and method for differential determination of leukocytes in blood
A white blood cell and red blood cell technology, applied in the field of dissolving agents, can solve problems such as prolonging reaction time, raising temperature, and reducing the working efficiency of automatic analyzers
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment I
[0057] Solvent compositions were formulated with the following components:
[0058] 1. T-mulz (Harcros Chemical, Inc., 50% potassium salt of organophosphate) 5.0 g
[0059] 2. Sodium lauryl sulfate 1.0g
[0060] 3. Hetoxol STA30 (Heterene, ethoxylated stearyl alcohol) 10.0g
[0061] 4. Pluronic 10R5 (BASF) 15.0g
[0062] 5. Formic acid 0.2ml
[0064] 7. Potassium chloride 6.0g
[0065] 8. BHT pre-dissolved in ethanol 0.05g
[0066] 9. proclin300 (Rohm & Haas Co.) 0.5ml
[0067] 10. PH (adjusted by 4M HCl) 2.2
[0068] 11. Adjust the deionized water to 1L
[0069] To 28ml of EDTA anticoagulated normal whole blood sample, add 1800ml of lysing agent composition, and at room temperature (about 212 ℃), mix the mixture gently by shaking for 9 seconds, after adding the lysing agent composition, about At 13 seconds ready for differential analysis. The blood mixture was maintained under acidic conditions (pH approximately 2.2) and an osmolality...
Embodiment II
[0071] A lyser composition was formulated with the following components and used in a leukocyte subpopulation differentiation assay. To 28 μl of EDTA anticoagulated normal whole blood sample, add 1600 μl of lysing agent composition, and at room temperature (approximately 212° C.), mix the mixture gently by shaking for 8 seconds, about 12 seconds after adding the lysing agent composition Seconds are ready for differential analysis. Figure 3a and 3b Two plots of DC versus turbidity are shown. Figure 3a Corresponding to normal blood samples, Figure 3b Corresponds to a blood sample with elevated eosinophils (manual differential count of 12%).
[0072] 1. Burco TME (Burlington Chemical Co. Inc., 1.5 g of ethoxylated dodecylmercaptan, HLB=13.0)
[0073] 2. Sodium lauryl sulfate 1.0g
[0074] 3. Hetoxol STA30 (Heterene, ethoxylated octadecyl alcohol 8.0g)
[0075] 4. Pluronic L35 (BASF) 10.0g
[0076] 5. Citric acid 17.0ml
[0077] 6. Sodium sulfate 9.0g
[0078] 7. Potas...
Embodiment III
[0082] A lyser composition was formulated with the following components and used in a leukocyte subpopulation differentiation assay. In 28 μl of EDTA anticoagulated normal whole blood sample, add about 1880 μl of lysing agent composition, and at room temperature (about 212 ℃), mix the mixture gently by shaking for 11 seconds, after adding the lysing agent composition about At 15 seconds ready for differential analysis. Samples were then analyzed on an experimental hematology analyzer.
[0083] 1. Tergitol NP-13 (Union Carbide, ethoxylated nonylphenol) 1.0g
[0084] 2. Sodium Tetradecyl Sulfate 1.0g
[0085] 3. Hetoxol STA30 (Heterene) 10.0g
[0086] 4. Formic acid 0.2g
[0087] 5. Sodium sulfate 9.0ml
[0088] 6. Potassium chloride 5.0g
[0089] 7. Pluronic 10R5 15.0g
[0090] 8. Adjust the deionized water to 1L
[0091] 9. PH 2.2
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 